Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.

MLA

Mastrangelo, Stefano, et al. “Treatment of Advanced Neuroblastoma in Children over 1 Year of Age: The Critical Role of ¹³¹I-Metaiodobenzylguanidine Combined with Chemotherapy in a Rapid Induction Regimen.” Pediatric Blood & Cancer, vol. 56, no. 7, July 2011, pp. 1032–40. EBSCOhost, https://doi.org/10.1002/pbc.22986.

APA

Mastrangelo, S., Rufini, V., Ruggiero, A., Di Giannatale, A., & Riccardi, R. (2011). Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. Pediatric Blood & Cancer, 56(7), 1032–1040. https://doi.org/10.1002/pbc.22986

Chicago

Mastrangelo, Stefano, Vittoria Rufini, Antonio Ruggiero, Angela Di Giannatale, and Riccardo Riccardi. 2011. “Treatment of Advanced Neuroblastoma in Children over 1 Year of Age: The Critical Role of ¹³¹I-Metaiodobenzylguanidine Combined with Chemotherapy in a Rapid Induction Regimen.” Pediatric Blood & Cancer 56 (7): 1032–40. doi:10.1002/pbc.22986.